Andrew D. Rackear's Net Worth
$65.8 Thousand
Who is Andrew D. Rackear?
Andrew D. Rackear does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ENZON PHARMACEUTICALS INC, and NPS PHARMACEUTICALS INC.
SEC CIK
Andrew D. Rackear's CIK is 0001408617
Past Insider Trading and Trends
2008 was Andrew D. Rackear's most active year for acquiring shares with 4 total transactions. Andrew D. Rackear's most active month to acquire stocks was the month of December. 2011 was Andrew D. Rackear's most active year for disposing of shares, totalling 2 transactions. Andrew D. Rackear's most active month to dispose stocks was the month of May. 2009 saw Andrew D. Rackear paying a total of $0.00 for 118,125 shares, this is the most they've acquired in one year. In 2011 Andrew D. Rackear cashed out on 5,833 shares for a total of $42,374.99, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.1601
CEO and SecretaryAndrew D. Rackear owns 78,019 units of Common Stock which is worth $12,490.84.acquired a total of 24,686 shares in ENZON PHARMACEUTICALS INC, Andrew also disposed a total of 7,447 shares of ENZON PHARMACEUTICALS INC equalling to $53,358.26.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.39% | 4.69K |
—
|
—
| 78.02K |
Jan 23
| |||
Form 4
| -2.77% | -1.61K |
$6.81 | -$10,983.27 | 56.72K |
Jun 5
| |||
Form 4
| +20.69% | 10K |
—
|
—
| 58.33K |
Jan 17
| |||
Form 4
| -7.23% | -3.77K |
$6.68 | -$25,156.88 | 48.33K |
Nov 10
| |||
Form 4
| -3.82% | -2.07K |
$8.33 | -$17,218.11 | 52.1K |
Sep 15
| |||
Form 4
| +22.64% | 10K |
—
|
—
| 54.17K |
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NPS PHARMACEUTICALS INC No price found
SVP, General Counsel & Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||